Validation of a Transfusion Prediction Model in Head and Neck Cancer Surgery

Archives of Otolaryngology - Head and Neck Surgery

Volumn 129, Issue 12, 2003, Pages 1297-1302

  Krupp, Nadia L ^a   Weinstein, Gregory ^a   Chalian, Ara ^a   Berlin, Jesse A ^a   Wolf, Patricia ^a   Weber, Randal S ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; AREA UNDER THE CURVE; ARTICLE; BLOOD AUTOTRANSFUSION; CALIBRATION; CANCER STAGING; CANCER SURGERY; COST UTILITY ANALYSIS; CURVE FITTING; FEMALE; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HEMOGLOBIN DETERMINATION; HIGH RISK PATIENT; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PLASTIC SURGERY; PREOPERATIVE EVALUATION; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; STATISTICAL MODEL; TRANSFUSION PREDICTION RISK ASSESSMENT MODEL;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; COST-BENEFIT ANALYSIS; CRITICAL PATHWAYS; DISCRIMINANT ANALYSIS; ERYTHROPOIETIN; FEMALE; HEAD AND NECK NEOPLASMS; HEMOGLOBINS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEEDS ASSESSMENT; NEOPLASM STAGING; PATIENT EDUCATION; PRACTICE GUIDELINES; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SURGICAL FLAPS;

EID: 0346850876     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.129.12.1297     Document Type: Article

References (10)

1. Dulguerov P, Quinodoz D, Allal AS, Tassonyi E, Beris P. Blood transfusion requirements in otolaryngology-head and neck surgery. Acta Otolaryngol(Stockh). 1998;118:744-747.
2. Weber RS. A model for predicting transfusion requirements in head and neck surgery. Laryngoscope. 1995;105(8, pt 2, suppl 73)1-17.
3. Husbands JM, Weber RS, Karpati RL, et al. Clinical care pathways: decreasing resource utilization in head and neck surgical patients. Otolaryngol Head Neck Surg. 1999;121:755-759.
4. DeLong ER, Peterson ED, DeLong DM, et al. Comparing risk-adjustment methods for provider profiling. Stat Med. 1997;16:2645-2664.
5. Peterson ED, DeLong ER, Muhlbaier LH, et al. Challenges in comparing riskadjusted bypass surgery mortality results. J Am Coll Cardiol. 2000;36:2174-2184.
6. Moir MS, Sami RN, Hanasono MM, Terris DJ. Autologous and heterologous blood transfusion in head and neck cancer surgery. Arch Otolaryngol Head Neck Surg. 1999;125:864-868.
7. Gall RM, Kerr PD. Use of preoperative erythropoietin in head and neck surgery. J Otolaryngol. 2000;29:131-134.
8. Sturgis EM, Gianoli GJ, Miller RH, Fisher JW. Avoiding transfusion in head and neck surgery: feasibility study of erythropoietin. Laryngoscope. 2000;110:51-57.
9. Markham A, Bryson HM. Epoetin alfa: a review of its pharmacodynamic and pharcokinetic properties and therapeutic use in nonrenal applications. Drugs. 1995; 49:232-254.
10. Goodnough LT, Rudnick S, Price TH, et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med. 1989;321:1163-1168.